Infant Formula GMPs Probed By EC As New Regs In The Pipeline
This article was originally published in The Tan Sheet
Executive Summary
The European Commission is examining the issue of microbiological risks associated with infant formula use in an effort to develop safety guidelines to manage these risks in the European Union
You may also be interested in...
Infant Formula Sterility, Preparation Education Advised By FDA Panel
Increased educational efforts to help avoid the risk of serious health problems resulting from Enterobacter sakazakii bacterial contamination of powdered infant formula were recommended by an FDA advisory group at a March 19 meeting in Riverdale, Md
Powdered Infant Formula Microbiological Testing Program Recommended
Industry and FDA should collaborate on a rigorous microbiological sampling program to test powdered infant formula for possible contaminants such as Enterobacter sakazakii bacteria, according to the agency's Food Advisory/Contaminants and Natural Toxicants Subcommittee
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC